Our CEO, Nicholas Reder, MD, MPH, is thrilled to attend the JP Morgan Healthcare Conference in San Francisco from January 12 to 16. He’s looking forward to connecting with professionals and industry leaders to discuss the transformative potential of 3D tissue imaging in advancing research and precision medicine.

At Alpenglow Biosciences, we’re pushing the boundaries of 3D spatial biology and 3D pathology, unlocking unprecedented insights that drive drug development and diagnostics breakthroughs. Nick is eager to share our 2025 milestones and explore collaborations to accelerate innovation in this exciting space.

📩 If you’re attending, we’d love to connect; contact us at 

https://www.alpenglowbiosciences.com/contact 

to schedule a meeting. 

Let’s shape the future of precision medicine together!